Efficacy and Safety of Toripalimab with Fruquintinib in the Third-Line Treatment of Refractory Advanced Metastatic Colorectal Cancer: Results of a Single-Arm, Single-Center, Prospective, Phase II Clinical Study.
Journal of Gastrointestinal Oncology（2023）
Key words
Fruquintinib,PD-1 inhibitors,metastatic colorectal cancer (mCRC),non-microsatellite instability high,mismatch repair proficient (non-MSI-H,pMMR)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined